FDA Gives TCA Cellular Therapy Green Light to Proceed with First ALS Adult Stem Cell Trial Using Patient’s Own Stem …
COVINGTON, La.—-TCA Cellular Therapy, LLC announced today that the U.S. Food and Drug Administration has approved its adult stem cell protocol to conduct Phase I clinical trials to treat Amyotrophic Lateral Sclerosis .
[Read the full article here]Related News:
FDA Gives TCA Cellular Therapy Green Light to Proceed with First ALS Adult Stem Cell Trial…
FDA Gives TCA Cellular Therapy Green Light To Proceed With First ALS Adult Stem Cell Trial Using Patient’s Own Stem Cells
FDA approves TCA-CT’s adult stem cell protocol for conducting Phase I clinical trials in ALS